Abstract
In this chapter, we discuss the toxicity-based dose-finding methods for two-agent combinations in phase I oncology trials. The model-based approaches, such as the continual reassessment method (CRM), have been gradually applied to single-agent trials to determine the maximum tolerated dose (MTD). By contrast, the rule-based approaches have commonly been applied to two-agent combination trials, probably due to the absence of well-understood model-based methods for two-agent combination trials. In developing a dose-finding method for two-agent combination trials, we require a reasonable model that can adequately capture joint toxicity probabilities for two agents, taking into consideration of possible interactions of the two agents on toxicity probability (such as synergistic or antagonistic effects). We provide an overview of two useful dose-finding approaches based on Bayesian copula-type models and partial orderings across dose levels for two-agent combination trials. We also supply examples of successful software implementations and discuss the operating characteristics of these approaches.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cheung, Y. K.: Dose Finding by the Continual Reassessment Method. New York, Chapman & Hall (2011)
Conaway, M. R., Dunbar, S., Peddada, S. D.: Designs for single- or multiple-agent phase I trials. Biometrics 60, 661–669 (2004)
Copas, J. B.: Regression, prediction and shrinkage. Journal of the Royal Statistical Society Series B 45, 311–354 (1983)
Copas, J. B.: Using regression models for prediction: Shrinkage and regression to the mean. Statistical Methods in Medical Research 6, 167–183 (1997)
Gasparini, M., Bailey, S., Neuenschwander, B.: Correspondence: Bayesian dose finding in oncology for drug combinations by copula regression. Journal of the Royal Statistical Society Series C 59, 543–546 (2010)
Goodman, S. N., Zahurak, M. L., Piantadosi, S.: Some practical improvements in the continual reassessment method for phase I studies. Statistics in Medicine 14, 1149–1161 (1995)
Hirakawa, A., Hamada, C., Matsui, S.: A dose-finding approach based on shrunken predictive probability for combinations of two agents in phase I trials. Statistics in Medicine 32, 4515–4525 (2013)
Lee, S. M., Cheung, Y. K.: Model calibration in the continual reassessment method. Clinical Trials 6, 227–238 (2009)
Lokich, J.: Phase I clinical trial of weekly combined topotecan and irinotecan. American Journal of Clinical Oncology 24, 336–40 (2001)
Nelsen, R. B.: An Introduction to Copulas, 2nd edn. New York, Springer (2006)
O’Quigley, J., Pepe, M., Fisher, L.: Continual reassessment method: A practical design for phase 1 clinical trials in cancer. Biometrics 46, 33–48 (1990).
O’Quigley, J., Shen, L. Z.: Continual reassessment method: A likelihood approach. Biometrics 52, 673–684 (1996)
Robertson, T., Wright, F. T., Dykstra, R. L., Dykstra, R.: Order Restricted Statistical Inference. New York, John Wiley & Sons (1988)
Thall, P. F., Millikan, R. E., Mueller, P., Lee, S. J.: Dose finding with two agents in phase I oncology trials. Biometrics 59, 487–496 (2003)
Wages, N. A., Conaway, M. R., O’Quigley, J.: Continual reassessment method for partial ordering. Biometrics 67, 1555–1563 (2011a)
Wages, N. A., Conaway, M. R., O’Quigley, J.: Dose-finding design for multi-drug combinations. Clinical Trials 8, 380–389 (2011b)
Wang, K., Ivanova, A.: Two-dimensional dose finding in discrete dose space. Biometrics 61, 217–222 (2005)
Yin, G., Yuan, Y.: A latent contingency table approach to dose finding for combinations of two agents. Biometrics 65, 866–875 (2009a)
Yin, G., Yuan, Y.: Bayesian dose finding in oncology for drug combinations by copula regression. Journal of the Royal Statistical Society Series C 58, 211–224 (2009b)
Acknowledgements
This work was partially supported by JSPS KAKENHI Grant Number 25730015 (Grant-in-Aid for Young Scientists B).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hirakawa, A., Matsui, S. (2014). Dose-Finding Methods for Two-Agent Combination Phase I Trials. In: van Montfort, K., Oud, J., Ghidey, W. (eds) Developments in Statistical Evaluation of Clinical Trials. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55345-5_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-55345-5_15
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-55344-8
Online ISBN: 978-3-642-55345-5
eBook Packages: Mathematics and StatisticsMathematics and Statistics (R0)